BioChroma - A New and Patented Technology for Processing Radioactive Wastewater from Nuclear Medicine Therapy Facilities in Hospitals and Clinics [0.03%]
用于医疗机构的放射性医疗废物处理的新技术BioChroma专利技术
José Canga Rodríguez
José Canga Rodríguez
After undergoing radionuclide therapy, patients generate wastewater with a considerable amount of radioactivity, which can reach levels of as much as 90% of the administered dose. Due to the risk of accumulation after discharge into the sew...
Radioiodine thyroid ablation in graves' hyperthyroidism: merits and pitfalls [0.03%]
Graves病甲亢的放射性碘清甲：利与弊
J F Nwatsock,D Taieb,L Tessonnier et al.
J F Nwatsock et al.
Ablative approaches using radioiodine are increasingly proposed for the treatment of Graves' disease (GD) but their ophthalmologic and biological autoimmune responses remain controversial and data concerning clinical and biochemical outcome...
Pituitary incidentalomas detected with technetium-99m MIBI in patients with suspected parathyroid adenoma: preliminary results [0.03%]
~99TC-MIBI甲状旁腺偶发瘤患者垂体意外瘤的检出及其初步分析
Ekaterina Tiktinsky,Tifha Horne,Michael Friger et al.
Ekaterina Tiktinsky et al.
Tc-99m MIBI (MIBI) is a cationic lipophilic agent, which has traditionally been used for myocardial perfusion scintigraphy, detection and monitoring of different benign and malignant tumors. The objective of this study was to evaluate the f...
The Conundrum of PET/MR [0.03%]
PET/MR的困惑
Anbalagan Kannivelu,Tian Yue Kok,Ajit Kumar Padhy
Anbalagan Kannivelu
Bone Scan "Hot Spot" at the Superior Lateral Orbital Margin Fronto-zygomatic Suture Uptake Characterized with Tc-99m MDP SPECT/CT [0.03%]
superior lateral orbital margin fronto-zygomatic suture 骨扫描异常摄取的 Tc-99m MDP SPECT/CT 血管造影特征：Hot Spot 报道
S P Thang,A E H Tan,A S W Goh
S P Thang
Findings of a solitary "hot spot" at the superior lateral orbital margin on bone scan scintigraphy is not uncommonly seen, and is often dismissed as a benign lesion. However, the exact etiology is indeterminate. We present two cases in whic...
Dosimetric considerations in radioimmunotherapy and systemic radionuclide therapies: a review [0.03%]
放射免疫治疗和全身性核素治疗的剂量学考量：综述文章
Kelvin S H Loke,Ajit K Padhy,David C E Ng et al.
Kelvin S H Loke et al.
Radiopharmaceutical therapy, once touted as the "magic bullet" in radiation oncology, is increasingly being used in the treatment of a variety of malignancies; albeit in later disease stages. With ever-increasing public and medical awarenes...
Improved quality of life in patients treated with Peptide radionuclides [0.03%]
肽类放射性核素治疗患者的改善生活质量研究
T Traub-Weidinger,M Raderer,M Uffmann et al.
T Traub-Weidinger et al.
Peptide receptor radionuclide therapy (PRRT) has recently been established as an important treatment modality for somatostatin receptor (SSTR)-positive tumors. The purpose of this study was to evaluate the clinical response, side-effects as...
A decade of the asian regional cooperative council for nuclear medicine: a path to reduce heterogeneity of nuclear medicine practice in Asia [0.03%]
亚洲核医学区域合作理事会的十年历程：减少亚洲核医学实践异质性的路径
Hee-Seung Bom,June-Key Chung,Myung-Chul Lee
Hee-Seung Bom
Welcome to saigon [0.03%]
欢迎来到西贡
Ajit Kumar Padhy
Ajit Kumar Padhy
Retroperitoneal Fibrosis Masquerading as Para-aortic Lymphadenopathy on F-18 FDG PET/CT in a Patient with Carcinoma Cervix [0.03%]
宫颈癌患者出现氟-18脱氧葡萄糖正电子发射体层显像/ X线计算机体层成像检查时，腹膜后纤维化假性淋巴结病變
R Kashyap,B R Mittal,S Kumari et al.
R Kashyap et al.
We present a case of carcinoma cervix found to have a soft tissue lesion in retroperitoneal region with intense FDG uptake. However, this FDG uptake was false positive as the final diagnosis was retroperitoneal fibrosis. ...